IL1 inhibition in gout-where are we a decade on?

Arthritis Res Ther. 2019 Nov 11;21(1):233. doi: 10.1186/s13075-019-2027-3.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antirheumatic Agents / pharmacology
  • Antirheumatic Agents / therapeutic use
  • Gout / blood
  • Gout / drug therapy*
  • Gout Suppressants / pharmacology
  • Gout Suppressants / therapeutic use*
  • Humans
  • Interleukin 1 Receptor Antagonist Protein / antagonists & inhibitors
  • Interleukin 1 Receptor Antagonist Protein / blood
  • Interleukin 1 Receptor Antagonist Protein / pharmacology
  • Interleukin 1 Receptor Antagonist Protein / therapeutic use*

Substances

  • Antirheumatic Agents
  • Gout Suppressants
  • IL1RN protein, human
  • Interleukin 1 Receptor Antagonist Protein